Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Specifically, high attained dose was associated with lower: all-cause mortality (RR = 0.42, P 25% group, with a mean patient-level change of 0.2% versus 0.8% relative to the pre-treatment baseline measurement ( P 25% weight loss group (126 mmHg versus 13 mmHg, P 25% weight loss group (75.4 mmHg versus 78.0 mmHg) and progressively larger patient-level declines relative to baseline across the different weight loss strata ( P = 0.002
Novo Nordisk is facing patent challenges around the world
Ship to a climate-controlled location
Source: Wharton S, et al
Factors affecting pricing include compounding pharmacy costs, active pharmaceutical ingredient availability and pricing, regulatory changes, operational expenses, market conditions, and individual patient circumstances
US$ 21.56
US$ 24.99
US$ 27.96
US$ 24.05
US$ 22.66
